Terms: = Prostate cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
15 results:
1. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in prostate and Other cancer Cell Types Mediate Cell Death.
Shoeib AM; Benson LN; Mu S; MacMillan-Crow LA; Prather PL
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328467
[TBL] [Abstract] [Full Text] [Related]
2. Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment.
Andrews JR; Hebert KJ; Boswell TC; Avant RA; Boonipatt T; Kreutz-Rodrigues L; Bakri K; Houdek MT; Karnes RJ; Viers BR
BJU Int; 2021 Oct; 128(4):460-467. PubMed ID: 33403768
[TBL] [Abstract] [Full Text] [Related]
3. Cannabinoids and prostate cancer: A Systematic Review of Animal Studies.
Singh K; Jamshidi N; Zomer R; Piva TJ; Mantri N
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872551
[TBL] [Abstract] [Full Text] [Related]
4. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
Roberto D; Klotz LH; Venkateswaran V
Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
[TBL] [Abstract] [Full Text] [Related]
5. treatment of stress urinary incontinence after prostatectomy with the adjustable transobturator male system (ATOMS®) with preattached scrotal port.
Esquinas C; Arance I; Pamplona J; Moraga A; Dorado JF; Angulo JC
Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):473-482. PubMed ID: 29642999
[TBL] [Abstract] [Full Text] [Related]
6. [Transperineal ultrasound imaging of the internal pudendal artery in arteriogenic erectile dysfunction].
Povelitsa E; Dosta NI; Parhomenko OV; Nitkin DM; Shesternja AM; Anichkin VV
Urologiia; 2017 Sep; (4):55-61. PubMed ID: 28952694
[TBL] [Abstract] [Full Text] [Related]
7. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
[TBL] [Abstract] [Full Text] [Related]
8. Survival Outcomes of Whole-Pelvic Versus prostate-Only Radiation Therapy for High-Risk prostate cancer Patients With Use of the National cancer Data Base.
Amini A; Jones BL; Yeh N; Rusthoven CG; Armstrong H; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1052-63. PubMed ID: 26581142
[TBL] [Abstract] [Full Text] [Related]
9. The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the treatment of cancer.
Xian S; Parayath NN; Nehoff H; Giles NM; Greish K
Anticancer Res; 2015 Sep; 35(9):4707-12. PubMed ID: 26254360
[TBL] [Abstract] [Full Text] [Related]
10. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract] [Full Text] [Related]
11. Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest.
Sarfaraz S; Afaq F; Adhami VM; Malik A; Mukhtar H
J Biol Chem; 2006 Dec; 281(51):39480-91. PubMed ID: 17068343
[TBL] [Abstract] [Full Text] [Related]
12. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
[TBL] [Abstract] [Full Text] [Related]
13. [Prostatic cancer: immunochemical control over chemotherapy].
Nikolaev AA; Lutskiĭ DL; Nikolaeva NN
Urologiia; 2000; (3):41-3. PubMed ID: 11186710
[TBL] [Abstract] [Full Text] [Related]
14. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
Ruiz L; Miguel A; Díaz-Laviada I
FEBS Lett; 1999 Sep; 458(3):400-4. PubMed ID: 10570948
[TBL] [Abstract] [Full Text] [Related]
15. Results of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy.
Mettlin CJ; Murphy GP; Sylvester J; McKee RF; Morrow M; Winchester DP
Cancer; 1997 Nov; 80(9):1875-81. PubMed ID: 9351563
[TBL] [Abstract] [Full Text] [Related]
